NXI Therapeutics
Immunosuppressive drugs manufacturer for autoimmune diseases and transplantations.
1
Funding Rounds
$3.9m
Money raised
Overview
Immunosuppressive drugs manufacturer for autoimmune diseases and transplantations.
- Website:
- Business model: B2C
- Headquarters: Basel
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company NXI Therapeutics has raised a total of $3.9m in funding over 1 rounds.
Key Insights:
- NXI Therapeutics June 2024 Pre-Seed Funding Round: $3.9m
NXI Therapeutics June 2024 Pre-Seed Funding Round
$3.9m
Industries
NXI Therapeutics is active in the following industries: